Managing eCOA Data: Best Practices Across the Clinical Trial Lifecycle

By: Steve Lyons, Vice President, Data Delivery and Integration Engineering, uMotif

When using electronic clinical outcome assessments (eCOA), ensuring clear stakeholder alignment throughout the lifecycle of a study regarding data management activities is critical to success.

Every aspect of a clinical trial—from demonstrating therapeutic benefit to monitoring participant safety—depends on the collection of accurate, reliable, and complete data. High-quality data enable both sponsors and regulators to make evidence-based decisions about the efficacy and safety of new treatments, as well as supporting decision-making by investigators during trial conduct.

When clinical outcome assessments are being captured electronically (eCOA)—including participant-reported outcome measures (ePROMs), clinician-reported outcomes (eClinROs), observer-reported outcomes (eObsROs), and performance outcome measures (ePerfOs)—ensuring clear stakeholder alignment throughout the lifecycle of a study with regard to data management activities is critical to streamline activities and study success.

Define Roles and Responsibilities

Successful eCOA data management begins with the very basic task of clearly defined roles and responsibilities among all stakeholders. These stakeholders typically include the sponsor, the eCOA technology provider, contract research organizations (CROs).

Clearly outlining responsibilities ensures that all parties understand who is accountable for tasks such as database configuration, data review, issue resolution, and system maintenance—especially for instances in which it could be either party that could conduct an activity. Establishing governance structures and communication pathways early in the study will help prevent delays and ensure that any data-related issues are addressed efficiently and in a timely manner.

Data management activities for eCOA systems span the full lifecycle of a clinical trial, from system set-up through study close-out.

1. Set-Up and Go-Live

Effective data management begins long before data collection actually starts, and the set-up phase lays the foundation for successful data collection. When the eCOA system is being designed and configured—including questionnaire design, visit schedules, reminders and alerts, reports, system integrations—data managers should be actively involved to ensure efficient downstream data handling.

Ensuring the right people from all organizations (sponsor, CRO, eCOA vendor) are represented during design meetings is key. It’s also vital to establish alignment between data managers from all parties on elements such as:

variable naming conventions
scoring and calculations
validation/edit check rules
data formats and metadata standards
analysis requirements
data change processes
data capture back-up methods
data access
data transfer frequency

It is also important that during user acceptance testing—where sponsors confirm that the system functions as expected (in line with the design specifications)—that data exports and reports are tested. This ensures that the data outputs from the eCOA are submitted and stored correctly.

“Establishing governance structures and communication pathways early in the study will help prevent delays and ensure that any data-related issues are addressed efficiently and in a timely manner. Data management activities for eCOA systems span the full lifecycle of a clinical trial, from system set-up through study close-out.”

2. Ongoing Study Conduct

Once the study is live and data starts to be captured, ongoing data monitoring becomes essential to ensure continuous data quality and system performance. Despite carefully designed protocols, systems, and site and participant training, mistakes happen and situations can arise during a trial when a data change is required.

Any requests to change data during a trial must have sound justification and follow a controlled data change request process, as outlined in the data management plan and agreed upon during set-up. All changes made should be clearly captured in the audit trail.

Regular meetings between data management teams should occur, and cover elements such as:

compliance
missing data
technical issues
data formatting
any integrations are functioning as expected
data change requests

3. Close-Out Activities

At the end of the study, close-out activities focus on ensuring the completeness and accuracy of the collected data before database lock. Key tasks include comprehensive data cleaning and the resolution of outstanding queries or discrepancies.

Data correction processes must follow defined procedures to maintain audit trails and regulatory compliance. Once all issues are resolved and the data are verified, the dataset can be finalized for statistical analysis and regulatory submission.

The Future: What Can AI Do?

Artificial intelligence is beginning to play a practical role in supporting eCOA data management by helping study teams identify issues earlier and work more efficiently. By reducing the time needed to review and interpret routine study data, AI has the potential to accelerate issue detection and improve overall data oversight.

AI can also help teams manage growing data volumes more effectively while maintaining high standards of data quality and integrity. For example, AI can help summarize study metrics, highlight emerging trends in participant compliance, and support faster review of data quality signals across sites and participants.

Further, AI models can help predict the likelihood of certain outcomes, such as which participants are at risk of missing diary entries or dropping out of the study. These insights allow study teams to intervene earlier, improving compliance and reducing missing data.

Another emerging application is automated anomaly detection across integrated study datasets. Because eCOA data often interact with other clinical data sources such as EDC, safety systems, and wearable device platforms, AI tools can help identify inconsistencies between systems more quickly than traditional rule-based checks alone.

Importantly, AI acts as a support tool for study teams rather than replacing established data management processes. Human oversight remains essential for interpreting findings and making decisions that affect study data, trial conduct, and that can impact participant safety.

Conclusion

As the use of digital tools continues to expand within clinical research, effective data management for eCOA systems is more important than ever. From initial design and system setup to ongoing monitoring and final data cleaning, each stage of the study lifecycle plays a role in ensuring the reliability and usability of collected outcomes data.

By clearly defining responsibilities, rigorously testing systems and data flows, and maintaining continuous oversight throughout the study, organizations can ensure that eCOA data contribute meaningfully to the scientific and regulatory evaluation of new therapies.

About the Author

Steve Lyons is Vice President of Data Delivery and Integration Engineering at uMotif, which offers an eConsent and eCOA/ePRO platform for clinical and real-world research.